MaxCyte, Inc. (MXCT)
USD 2.6
(-5.8%)
USD 2.6
(-5.8%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | -48.29 Million USD | -76.22% |
| 2022 | -27.36 Million USD | -50.43% |
| 2021 | -18.18 Million USD | -64.5% |
| 2020 | -11.05 Million USD | 10.98% |
| 2019 | -12.42 Million USD | -47.42% |
| 2018 | -8.42 Million USD | 9.33% |
| 2017 | -9.29 Million USD | -241.18% |
| 2016 | -2.72 Million USD | -257.82% |
| 2015 | -761.1 Thousand USD | 40.34% |
| 2014 | -1.27 Million USD | -58.53% |
| 2013 | -804.7 Thousand USD | 59.0% |
| 2012 | -1.96 Million USD | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q2 | -11.94 Million USD | 2.46% |
| 2024 Q1 | -12.24 Million USD | -51.58% |
| 2023 Q2 | -13.07 Million USD | 0.79% |
| 2023 Q3 | -13.95 Million USD | -6.73% |
| 2023 Q1 | -13.17 Million USD | -95.21% |
| 2023 Q4 | -8.07 Million USD | 42.12% |
| 2023 FY | -48.21 Million USD | -76.22% |
| 2022 Q4 | -6.75 Million USD | 12.47% |
| 2022 Q3 | -7.71 Million USD | 11.75% |
| 2022 Q2 | -8.73 Million USD | -110.12% |
| 2022 FY | -27.36 Million USD | -50.43% |
| 2022 Q1 | -4.15 Million USD | 16.07% |
| 2021 Q4 | -4.95 Million USD | -102.84% |
| 2021 FY | -18.18 Million USD | -64.5% |
| 2021 Q2 | -4.41 Million USD | 30.69% |
| 2021 Q3 | -2.44 Million USD | 44.7% |
| 2021 Q1 | -6.37 Million USD | -167.61% |
| 2020 FY | -11.05 Million USD | 10.98% |
| 2020 Q3 | -2.84 Million USD | 0.08% |
| 2020 Q4 | -2.38 Million USD | 16.21% |
| 2020 Q2 | -2.84 Million USD | 4.81% |
| 2020 Q1 | -2.98 Million USD | -72.67% |
| 2019 Q4 | -1.73 Million USD | 0.0% |
| 2019 FY | -12.42 Million USD | -47.42% |
| 2019 Q3 | -1.73 Million USD | 61.36% |
| 2019 Q2 | -4.47 Million USD | 0.0% |
| 2019 Q1 | -4.47 Million USD | -127.4% |
| 2018 Q4 | -1.96 Million USD | 0.0% |
| 2018 FY | -8.42 Million USD | 9.33% |
| 2018 Q2 | -2.24 Million USD | 0.0% |
| 2018 Q3 | -1.96 Million USD | 12.16% |
| 2018 Q1 | -2.24 Million USD | 15.48% |
| 2017 Q1 | -1.99 Million USD | -125.41% |
| 2017 Q2 | -1.99 Million USD | 0.0% |
| 2017 Q4 | -2.65 Million USD | 0.0% |
| 2017 Q3 | -2.65 Million USD | -33.15% |
| 2017 FY | -9.29 Million USD | -241.18% |
| 2016 Q1 | -477.7 Thousand USD | -453.86% |
| 2016 FY | -2.72 Million USD | -257.82% |
| 2016 Q4 | -884 Thousand USD | 0.0% |
| 2016 Q3 | -884 Thousand USD | -85.05% |
| 2016 Q2 | -477.7 Thousand USD | 0.0% |
| 2015 Q3 | -86.25 Thousand USD | 70.69% |
| 2015 Q2 | -294.3 Thousand USD | 0.0% |
| 2015 Q1 | -294.3 Thousand USD | -64.69% |
| 2015 FY | -761.1 Thousand USD | 40.34% |
| 2015 Q4 | -86.25 Thousand USD | 0.0% |
| 2014 FY | -1.27 Million USD | -58.53% |
| 2014 Q4 | -178.7 Thousand USD | 0.0% |
| 2014 Q1 | -459.15 Thousand USD | 0.0% |
| 2014 Q2 | -459.15 Thousand USD | 0.0% |
| 2014 Q3 | -178.7 Thousand USD | 61.08% |
| 2013 FY | -804.7 Thousand USD | 59.0% |
| 2012 FY | -1.96 Million USD | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Acutus Medical, Inc. | -14.36 Million USD | -236.321% |
| Cerus Corporation | -30.05 Million USD | -60.713% |
| OrthoPediatrics Corp. | -25.76 Million USD | -87.452% |
| PetVivo Holdings, Inc. | -10.62 Million USD | -354.735% |
| Talis Biomedical Corporation | -66.81 Million USD | 27.712% |
| Vivos Therapeutics, Inc. | -17.29 Million USD | -179.25% |
| Inogen, Inc. | -109.38 Million USD | 55.845% |
| Spectral AI, Inc. | -12.98 Million USD | -271.989% |
| Nano-X Imaging Ltd. | -62.58 Million USD | 22.831% |
| CVRx, Inc. | -43.1 Million USD | -12.055% |
| DIH Holding US, Inc. Warrants | -3.52 Million USD | -1269.019% |
| Helius Medical Technologies, Inc. | -12.42 Million USD | -288.631% |
| Orthofix Medical Inc. | -139.11 Million USD | 65.28% |
| Venus Concept Inc. | -28.3 Million USD | -70.614% |
| Accelerate Diagnostics, Inc. | -54.02 Million USD | 10.604% |
| Bioventus Inc. | -81.72 Million USD | 40.901% |
| BrainsWay Ltd. | -4.92 Million USD | -880.292% |
| Envoy Medical, Inc. | -18.37 Million USD | -162.909% |
| electroCore, Inc. | -18.8 Million USD | -156.841% |
| IceCure Medical Ltd | -15.57 Million USD | -210.086% |
| Lucid Diagnostics Inc. | -48.48 Million USD | 0.377% |
| Monogram Orthopaedics, Inc. | -17.26 Million USD | -179.702% |
| NeuroOne Medical Technologies Corporation | -11.95 Million USD | -303.998% |
| Nexalin Technology, Inc. | -5.69 Million USD | -747.902% |
| PAVmed Inc | -68.79 Million USD | 29.793% |
| Rapid Micro Biosystems, Inc. | -56.56 Million USD | 14.61% |
| RxSight, Inc. | -50.08 Million USD | 3.566% |
| Sight Sciences, Inc. | -57.27 Million USD | 15.67% |
| SI-BONE, Inc. | -46.93 Million USD | -2.915% |
| TELA Bio, Inc. | -44.07 Million USD | -9.584% |
| TriSalus Life Sciences, Inc. | -54.15 Million USD | 10.805% |
| Treace Medical Concepts, Inc. | -51.42 Million USD | 6.084% |
| LivaNova PLC | -68.49 Million USD | 29.488% |
| 908 Devices Inc. | -42.75 Million USD | -12.959% |
| Alphatec Holdings, Inc. | -173.39 Million USD | 72.145% |
| Nemaura Medical Inc. | -9.59 Million USD | -403.364% |
| NeuroPace, Inc. | -27.17 Million USD | -77.74% |
| LENSAR, Inc. | -12.22 Million USD | -294.955% |
| Apyx Medical Corporation | -17.25 Million USD | -179.848% |
| Cutera, Inc. | -156.23 Million USD | 69.085% |
| STRATA Skin Sciences, Inc. | -8.6 Million USD | -461.355% |
| BioSig Technologies, Inc. | -28.51 Million USD | -69.399% |
| Anika Therapeutics, Inc. | -87.63 Million USD | 44.889% |
| ClearPoint Neuro, Inc. | -22.44 Million USD | -115.179% |
| Integra LifeSciences Holdings Corporation | 111.52 Million USD | 143.307% |
| Axonics, Inc. | -26.05 Million USD | -85.359% |
| Outset Medical, Inc. | -169.77 Million USD | 71.55% |
| IRIDEX Corporation | -10 Million USD | -382.652% |
| PROCEPT BioRobotics Corporation | -109.17 Million USD | 55.758% |
| IRadimed Corporation | 20.03 Million USD | 341.068% |
| Tivic Health Systems, Inc. | -8.24 Million USD | -485.798% |
| INVO Bioscience, Inc. | -6.76 Million USD | -613.727% |
| Telesis Bio, Inc. | -35.15 Million USD | -37.408% |
| Viemed Healthcare, Inc. | 14.33 Million USD | 437.048% |
| Varex Imaging Corporation | 32.1 Million USD | 250.464% |
| Quipt Home Medical Corp. | 3.91 Million USD | 1332.432% |
| Inspira Technologies Oxy B.H.N. Ltd. | -12.13 Million USD | -298.08% |
| Pulmonx Corporation | -61.93 Million USD | 22.017% |
| Dynatronics Corporation | -2.27 Million USD | -2024.856% |
| Modular Medical, Inc. | -17.52 Million USD | -175.538% |
| ReShape Lifesciences Inc. | -14.63 Million USD | -229.934% |
| Semler Scientific, Inc. | 22.25 Million USD | 317.016% |
| InMode Ltd. | 195.66 Million USD | 124.685% |
| Bruker Corporation | 436.9 Million USD | 111.055% |
| Cytosorbents Corporation | -31.2 Million USD | -54.759% |
| DexCom, Inc. | 597.7 Million USD | 108.081% |
| Align Technology, Inc. | 643.33 Million USD | 107.508% |
| Viveve Medical, Inc. | -21.55 Million USD | -124.094% |
| ZimVie Inc. | -30.93 Million USD | -56.11% |
| Movano Inc. | -29.69 Million USD | -62.678% |
| Cytek Biosciences, Inc. | -27.84 Million USD | -73.457% |
| Nexalin Technology, Inc. | -5.69 Million USD | -747.902% |
| DIH Holdings US, Inc. Class A Common Stock | -3.52 Million USD | -1269.019% |
| Tandem Diabetes Care, Inc. | -233.23 Million USD | 79.291% |
| Profound Medical Corp. | -28.61 Million USD | -68.783% |
| Insulet Corporation | 220 Million USD | 121.954% |
| enVVeno Medical Corporation | -25.23 Million USD | -91.374% |
| Surmodics, Inc. | -5.64 Million USD | -755.607% |
| iCAD, Inc. | -7.68 Million USD | -528.157% |
| Nuwellis, Inc. | -17.63 Million USD | -173.959% |
| Biotricity, Inc. | -8.82 Million USD | -447.095% |
| iRhythm Technologies, Inc. | -125.16 Million USD | 61.411% |
| Aethlon Medical, Inc. | -12.63 Million USD | -282.216% |
| InspireMD, Inc. | -21.14 Million USD | -128.44% |
| PAVmed Inc. | -68.79 Million USD | 29.793% |
| BIOLASE, Inc. | -17.93 Million USD | -169.27% |
| Beyond Air, Inc. | -63 Million USD | 23.342% |
| FONAR Corporation | 16.53 Million USD | 392.095% |
| AxoGen, Inc. | -21.46 Million USD | -125.044% |
| Vivani Medical, Inc. | -26.96 Million USD | -79.117% |
| Tactile Systems Technology, Inc. | 18.04 Million USD | 367.718% |
| Inari Medical, Inc. | -14.03 Million USD | -244.206% |
| UFP Technologies, Inc. | 57.66 Million USD | 183.759% |
| QT Imaging Holdings, Inc. | -4.92 Million USD | -880.173% |
| Heart Test Laboratories, Inc. | -6.3 Million USD | -665.949% |
| Tenon Medical, Inc. | -15.72 Million USD | -207.109% |
| Autonomix Medical, Inc. Common Stock | -7.47 Million USD | -546.227% |
| Co-Diagnostics, Inc. | -42.7 Million USD | -13.096% |
| AdaptHealth Corp. | -598.4 Million USD | 91.929% |
| Sintx Technologies, Inc. | -13.35 Million USD | -261.574% |
| NanoVibronix, Inc. | -3.43 Million USD | -1305.675% |
| Quanterix Corporation | -49.7 Million USD | 2.821% |
| Inspira Technologies Oxy B.H.N. Ltd. | -12.13 Million USD | -298.08% |
| Sensus Healthcare, Inc. | -382 Thousand USD | -12543.717% |
| Pacific Biosciences of California, Inc. | -334.46 Million USD | 85.559% |
| TransMedics Group, Inc. | -28.72 Million USD | -68.131% |
| ReWalk Robotics Ltd. | -23.61 Million USD | -104.553% |
| NeuroMetrix, Inc. | -7.15 Million USD | -575.367% |
| Hyperfine, Inc. | -48.11 Million USD | -0.382% |
| Establishment Labs Holdings Inc. | -65.02 Million USD | 25.724% |
| Biomerica, Inc. | -6.36 Million USD | -658.583% |
| Bone Biologics Corporation | -9.42 Million USD | -412.277% |
| AVITA Medical, Inc. | -40.4 Million USD | -19.546% |
| Bluejay Diagnostics, Inc. | -10.31 Million USD | -368.412% |
| Silk Road Medical, Inc | -59.27 Million USD | 18.512% |